Marketing-authorisation holder · Canada
Bgp Pharma Ulc
146 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
146 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 146
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ANDROGEL1 % · Gel | Testosterone | Canada | Marketed | 2002 |
| ANDROGEL1 % · Gel | Testosterone | Canada | Marketed | 2002 |
| ANDROGEL12.5 mg / act · Gel | Testosterone | Canada | Marketed | 2004 |
| BIAXIN250 mg / 5 ml · Granules For Suspension | Clarithromycin | Canada | Marketed | 2002 |
| BIAXIN125 mg / 5 ml · Granules For Suspension | Clarithromycin | Canada | Marketed | 1995 |
| BIAXIN BID250 mg · Tablet | Clarithromycin | Canada | Marketed | 1992 |
| BIAXIN BID500 mg · Tablet | Clarithromycin | Canada | Marketed | 1994 |
| CADUET10 mg + 10 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET5 mg + 80 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET5 mg + 20 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET5 mg + 10 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET10 mg + 40 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET10 mg + 80 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET10 mg + 20 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CADUET5 mg + 40 mg · Tablet | Amlodipine, Atorvastatin | Canada | Marketed | 2005 |
| CELEBREX100 mg · Capsule | Celecoxib | Canada | Marketed | 1999 |
| CELEBREX200 mg · Capsule | Celecoxib | Canada | Marketed | 1999 |
| CREON MINIMICROSPHERES 1011200 unit + 10000 unit + 730 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1996 |
| CREON MINIMICROSPHERES 2022400 unit + 20000 unit + 1460 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Authorised | |
| CREON MINIMICROSPHERES 2525500 unit + 25000 unit + 1600 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 1992 |
| CREON MINIMICROSPHERES 3535700 unit + 35000 unit + 2240 unit · Capsule (Delayed-Release) | Amylase, Lipase, Protease | Canada | Marketed | 2021 |
| CREON MINIMICROSPHERES MICRO5100 unit / 100 mg + 5000 unit / 100 mg + 320 unit / 100 mg · Granules For Suspension (Delayed-Release | Amylase, Lipase, Protease | Canada | Marketed | 2015 |
| DEPAKENE250 mg / 5 ml · Solution | Valproic acid | Canada | Marketed | 1978 |
| DETROL1 mg · Tablet | Tolterodine | Canada | Marketed | 1998 |
| DETROL2 mg · Tablet | Tolterodine | Canada | Marketed | 1998 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 146 | 120 | 26 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.